Between these groups, no significant differences were found in hypertension treatment: 47.6% vs. 52% used ACE inhibitors; 40.5% vs. 44% ARBs, other hypertensives 21.4% vs. 28%, respectively. The gene discussed is ACE; the disease is hypertensive disorder.